Martin P Schwellnus1, Siddieq Allie, Wayne Derman, Malcolm Collins. 1. Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, South Africa. martin.schwellnus@uct.ac.za
Abstract
BACKGROUND: Despite the high prevalence of exercise-associated muscle cramping (EAMC) in endurance runners, the aetiology and risk factors for this condition are not fully understood. PURPOSE: The purpose of this prospective cohort study was to identify risk factors associated with the development of EAMC in ultra-distance runners. METHODS: 49 runners participating in a 56 km race completed a validated pre-race questionnaire. Pre-race muscle pain in the calves, hamstrings and quadriceps muscles was recorded (visual analogue scale) and pre-race serum creatine kinase (CK) activity was measured. 20 runners reported EAMC (EAMC group) during or within 6 h after the event, while 29 runners reported no cramping (CON group). RESULTS: EAMC was not associated with age, body mass index, sex, recent and past personal best running times, pre-race muscle pain and pre-race training (duration and frequency). Runners in the EAMC group tended to report on average longer training sessions during the 3 days before the race (EAMC 1.2 (1.1), CON 0.6 (1.0); p=0.077). Significant risk factors for EAMC were a past history of EAMC (EAMC 100%, CON 48%; p<0.001) and a faster running time (min) for the first 28 km split time of the race (EAMC 144 (20), CON 157 (14); p=0.029) despite being matched for recent (<15 weeks before race) personal best times in the 42.2 km race. Pre-race CK activity tended to be higher in the EAMC group (EAMC 89 (80), CON 58 (35); p=0.066). CONCLUSIONS: Novel risk factors for EAMC in distance runners are a past history of EAMC, faster running pace at the early stage of a race and possibly pre-race muscle damage.
BACKGROUND: Despite the high prevalence of exercise-associated muscle cramping (EAMC) in endurance runners, the aetiology and risk factors for this condition are not fully understood. PURPOSE: The purpose of this prospective cohort study was to identify risk factors associated with the development of EAMC in ultra-distance runners. METHODS: 49 runners participating in a 56 km race completed a validated pre-race questionnaire. Pre-race muscle pain in the calves, hamstrings and quadriceps muscles was recorded (visual analogue scale) and pre-race serum creatine kinase (CK) activity was measured. 20 runners reported EAMC (EAMC group) during or within 6 h after the event, while 29 runners reported no cramping (CON group). RESULTS:EAMC was not associated with age, body mass index, sex, recent and past personal best running times, pre-race muscle pain and pre-race training (duration and frequency). Runners in the EAMC group tended to report on average longer training sessions during the 3 days before the race (EAMC 1.2 (1.1), CON 0.6 (1.0); p=0.077). Significant risk factors for EAMC were a past history of EAMC (EAMC 100%, CON 48%; p<0.001) and a faster running time (min) for the first 28 km split time of the race (EAMC 144 (20), CON 157 (14); p=0.029) despite being matched for recent (<15 weeks before race) personal best times in the 42.2 km race. Pre-race CK activity tended to be higher in the EAMC group (EAMC 89 (80), CON 58 (35); p=0.066). CONCLUSIONS: Novel risk factors for EAMC in distance runners are a past history of EAMC, faster running pace at the early stage of a race and possibly pre-race muscle damage.
Authors: Douglas J Casa; Julie K DeMartini; Michael F Bergeron; Dave Csillan; E Randy Eichner; Rebecca M Lopez; Michael S Ferrara; Kevin C Miller; Francis O'Connor; Michael N Sawka; Susan W Yeargin Journal: J Athl Train Date: 2015-09 Impact factor: 2.860
Authors: Kevin C Miller; Brendon P McDermott; Susan W Yeargin; Aidan Fiol; Martin P Schwellnus Journal: J Athl Train Date: 2021-06-29 Impact factor: 2.860
Authors: Eleftherios Veniamakis; Georgios Kaplanis; Panagiotis Voulgaris; Pantelis T Nikolaidis Journal: Int J Environ Res Public Health Date: 2022-03-19 Impact factor: 3.390